Paul M Loadman Selected Research

Paul M Loadman Research Topics

Disease

42	Neoplasms (Cancer) 11/2023 - 06/2003
13	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 08/2010
8	Neoplasm Metastasis (Metastasis) 11/2023 - 04/2005
6	Polyps 11/2023 - 07/2013
4	Hypoxia (Hypoxemia) 01/2016 - 01/2007
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013 - 05/2004
3	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 02/2008
3	Adenoma (Adenomas) 12/2018 - 08/2010
3	Adenocarcinoma 07/2015 - 06/2003
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2014 - 08/2010
3	Colonic Neoplasms (Colon Cancer) 06/2013 - 06/2003
3	Transitional Cell Carcinoma 01/2013 - 04/2005
2	Hemorrhage 01/2023 - 12/2018
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2021
2	Inflammation (Inflammations) 11/2014 - 01/2014
2	Breast Neoplasms (Breast Cancer) 02/2014 - 05/2009
2	Necrosis 02/2014 - 09/2010
1	Adenomatous Polyps 11/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2021
1	Non-Muscle Invasive Bladder Neoplasms 01/2019
1	Glioma (Gliomas) 01/2017
1	Hypertension (High Blood Pressure) 02/2016
1	Virus Diseases (Viral Diseases) 02/2016
1	Colitis-Associated Neoplasms 11/2014

Drug/Important Bio-Agent (IBA)

12	Eicosapentaenoic AcidIBA 11/2023 - 08/2010
10	ProdrugsIBA 01/2019 - 02/2004
9	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2023 - 08/2010
7	Proteins (Proteins, Gene)FDA Link 12/2021 - 06/2003
6	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022 - 06/2003
6	DuocarmycinsIBA 01/2022 - 01/2013
6	polysialic acidIBA 05/2021 - 01/2013
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023 - 07/2013
5	EnzymesIBA 01/2021 - 06/2013
4	Nonesterified Fatty Acids (NEFA)IBA 11/2023 - 08/2010
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2013
3	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 11/2004
3	Cytotoxins (Cytolysins)IBA 06/2013 - 12/2009
3	TubulinIBA 12/2012 - 02/2004
3	ParaffinIBA 05/2009 - 05/2004
2	Dinoprostone (PGE2)FDA Link 11/2023 - 10/2023
2	insulin receptor-related receptor (IRR)IBA 11/2023 - 10/2023
2	Colchicine FDA LinkGeneric 01/2022 - 12/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2020
2	apaziquone (E 09)IBA 01/2019 - 10/2006
2	CarbohydratesIBA 10/2016 - 01/2016
2	PolymersIBA 10/2016 - 01/2016
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2016 - 01/2013
2	Peptides (Polypeptides)IBA 04/2014 - 05/2009
2	ICT2588IBA 04/2014 - 09/2010
2	Membrane-Associated Matrix MetalloproteinasesIBA 02/2014 - 09/2010
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 08/2013 - 01/2013
2	AQ4NIBA 12/2009 - 02/2008
2	Formaldehyde (Formol)FDA Link 05/2009 - 10/2004
1	EstersIBA 11/2023
1	eicosapentaenoic acid ethyl esterIBA 11/2023
1	Glycoproteins (Glycoprotein)IBA 11/2023
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2023
1	LipidsIBA 11/2023
1	Lipoxygenase (Lipoxygenase-1)IBA 11/2023
1	OxylipinsIBA 11/2023
1	N- (1- (7- fluoro- 2- (pyridin- 2- yl)quinolin- 3- yl)ethyl)- 9H- purin- 6- amineIBA 01/2022
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 05/2021
1	Polysaccharides (Glycans)IBA 05/2021
1	endo-alpha-sialidaseIBA 05/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	hydroxide ionIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	CarcinogensIBA 01/2021
1	Liposomes (Liposome)IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	GlycosyltransferasesIBA 10/2016
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2016
1	Peptide Hydrolases (Proteases)FDA Link 02/2016
1	Cell Adhesion MoleculesIBA 01/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 07/2015
1	vadimezanIBA 07/2015
1	Dietary Fats (Dietary Fat)IBA 11/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2014
1	von Willebrand FactorIBA 04/2014
1	Indicators and Reagents (Reagents)IBA 04/2014
1	Ferrosoferric Oxide (Magnetite)FDA Link 02/2014
1	cyclopropapyrroloindoleIBA 08/2013
1	Fish OilsIBA 07/2013
1	Warfarin (Coumadin)FDA LinkGeneric 07/2013
1	Mixed Function Oxygenases (Monooxygenases)IBA 06/2013
1	(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)(5- fluoro- 1H- indol- 2- yl)methanoneIBA 06/2013

Therapy/Procedure

11	Therapeutics 11/2023 - 10/2004
4	Chemoprevention 11/2023 - 07/2013
4	Precision Medicine 01/2019 - 02/2014
3	Drug Therapy (Chemotherapy) 01/2021 - 06/2013
2	Radiotherapy 01/2021 - 01/2019
2	Lasers (Laser) 07/2015 - 11/2011
1	Immunotherapy 01/2021
1	Intravenous Injections 01/2020
1	Microbubbles 01/2020
1	Oral Administration 11/2014
1	Intravenous Administration 02/2014
1	Gastrectomy 01/2014
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2014